These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36172180)

  • 1. Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and
    Lei S; Zhao S; Huang X; Feng Y; Li Z; Chen L; Huang P; Guan H; Zhang H; Wu Q; Chen B
    Front Pharmacol; 2022; 13():967623. PubMed ID: 36172180
    [No Abstract]   [Full Text] [Related]  

  • 2. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
    Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors.
    Nie H; Deng Y; Zheng C; Pan M; Xie J; Zhang Y; Yang Q
    J Cell Mol Med; 2020 May; 24(9):5168-5184. PubMed ID: 32189432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
    Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
    J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huangqin-Huanglian Decoction Protects Liver against Non-alcoholic Fatty Liver Disease in High Fat-diet Mice.
    Yang H; Wei D; Zhang Y; Jian W
    Endocr Metab Immune Disord Drug Targets; 2024; 24(6):691-708. PubMed ID: 37859322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease.
    Zhu T; Huang X; Zhu H; Chen J; Yao H; Zhang Y; Hua H; Zhang J; Qi J
    Phytomedicine; 2024 Jan; 123():155173. PubMed ID: 37976695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Protective Effects and Mechanism of Huaji Jianpi Decoction against Nonalcoholic Fatty Liver Disease by Network Pharmacology and Experimental Validation.
    Xue H; Wang Y; Xiang H; Song Q; Zhang G; Wang J; Ge S
    Evid Based Complement Alternat Med; 2022; 2022():5440347. PubMed ID: 36199550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of Chaihu Shugan Powder () for Treating Depression Based on Network Pharmacology.
    Liu YY; Hu D; Fan QQ; Zhang XH; Zhu YC; Ni MY; Wang YM; Zhang LK; Sheng L
    Chin J Integr Med; 2020 Dec; 26(12):921-928. PubMed ID: 31630361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease.
    Zhang Q; Zhang L; Liu K; Shang H; Ruan J; Yu Z; Meng S; Liang F; Wang T; Zhang H; Peng W; Wang Y; Chen J; Xiao T; Wang B
    Evid Based Complement Alternat Med; 2022; 2022():1638740. PubMed ID: 35178098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance.
    Jia KK; Pan SM; Ding H; Liu JH; Zheng YJ; Wang SJ; Pan Y; Kong LD
    Biomed Pharmacother; 2018 Jul; 103():1415-1428. PubMed ID: 29864926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology and experimental studies for deciphering the molecular targets and mechanisms of Chaihu Shugan powder in the treatment of functional dyspepsia.
    Wang Y; Wang X; Jiang K; Yang K; Ling J
    Technol Health Care; 2023; 31(S1):449-462. PubMed ID: 37038797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
    Lambertucci F; Arboatti A; Sedlmeier MG; Motiño O; Alvarez ML; Ceballos MP; Villar SR; Roggero E; Monti JA; Pisani G; Quiroga AD; Martín-Sanz P; Carnovale CE; Francés DE; Ronco MT
    J Nutr Biochem; 2018 Aug; 58():17-27. PubMed ID: 29860102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification.
    Li H; Niu L; Wang M; Liu C; Wang Y; Su Y; Yang Y
    Heliyon; 2024 Aug; 10(15):e35491. PubMed ID: 39170438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explore the Mechanism of Astragalus mongholicus Bunge against Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Experimental Verification.
    Fu L; Wu Z; Chu Y; Chen W; Gao L; Mu S; Zhao J
    Gastroenterol Res Pract; 2022; 2022():4745042. PubMed ID: 35422858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of Astragali Radix-Puerariae Lobatae Radix combination in regulating type 2 diabetes mellitus through AMPK signaling pathway: based on network pharmacology and experimental verification].
    Wei S; Li J; Han DW; Fu Q; Hao F
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2738-2749. PubMed ID: 35718494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Protective Effects and Mechanism of Crocetin From Saffron Against NAFLD by Network Pharmacology and Experimental Validation.
    Xu Z; Lin S; Gong J; Feng P; Cao Y; Li Q; Jiang Y; You Y; Tong Y; Wang P
    Front Med (Lausanne); 2021; 8():681391. PubMed ID: 34179049
    [No Abstract]   [Full Text] [Related]  

  • 18. Network pharmacology analysis on mechanism of Jian Pi Qing Gan Yin decoction ameliorating high fat diet-induced non-alcoholic fatty liver disease and validated in vivo.
    Liu W; Shang J; Deng Y; Han X; Chen Y; Wang S; Yang R; Dong F; Shang H
    J Ethnopharmacol; 2022 Sep; 295():115382. PubMed ID: 35577161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Shugan-Jianpi Recipe on the Expression of the p38 MAPK/NF-κB Signaling Pathway in the Hepatocytes of NAFLD Rats.
    Deng Y; Tang K; Chen R; Liu Y; Nie H; Wang H; Zhang Y; Yang Q
    Medicines (Basel); 2018 Sep; 5(3):. PubMed ID: 30235843
    [No Abstract]   [Full Text] [Related]  

  • 20. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
    Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
    J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.